These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 11521748)

  • 1. Involvement of corticotropin-releasing factor subtype 1 receptor in the acquisition phase of learned helplessness in rats.
    Takamori K; Kawashima N; Chaki S; Nakazato A; Kameo K
    Life Sci; 2001 Aug; 69(11):1241-8. PubMed ID: 11521748
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Involvement of the hypothalamus-pituitary-adrenal axis in antidepressant activity of corticotropin-releasing factor subtype 1 receptor antagonists in the rat learned helplessness test.
    Takamori K; Kawashima N; Chaki S; Nakazato A; Kameo K
    Pharmacol Biochem Behav; 2001; 69(3-4):445-9. PubMed ID: 11509203
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antidepressant-like effects of CP-154,526, a selective CRF1 receptor antagonist.
    Mansbach RS; Brooks EN; Chen YL
    Eur J Pharmacol; 1997 Mar; 323(1):21-6. PubMed ID: 9105872
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Receptor binding, behavioral, and electrophysiological profiles of nonpeptide corticotropin-releasing factor subtype 1 receptor antagonists CRA1000 and CRA1001.
    Okuyama S; Chaki S; Kawashima N; Suzuki Y; Ogawa S; Nakazato A; Kumagai T; Okubo T; Tomisawa K
    J Pharmacol Exp Ther; 1999 May; 289(2):926-35. PubMed ID: 10215672
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of dorsal periaqueductal gray CRF1- and CRF2-receptor stimulation in animal models of panic.
    Sergio Tde O; Spiacci A; Zangrossi H
    Psychoneuroendocrinology; 2014 Nov; 49():321-30. PubMed ID: 25146701
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Both corticotropin-releasing factor receptor type 1 and type 2 are involved in stress-induced inhibition of food intake in rats.
    Sekino A; Ohata H; Mano-Otagiri A; Arai K; Shibasaki T
    Psychopharmacology (Berl); 2004 Oct; 176(1):30-8. PubMed ID: 15071721
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of the CRF
    Wróbel A; Serefko A; Szopa A; Rojek K; Poleszak E; Skalicka-Woźniak K; Dudka J
    Naunyn Schmiedebergs Arch Pharmacol; 2017 Aug; 390(8):769-774. PubMed ID: 28429110
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of CP 154,526, a CRF1 receptor antagonist, on behavioral responses to cocaine in rats.
    Przegaliński E; Filip M; Frankowska M; Zaniewska M; Papla I
    Neuropeptides; 2005 Oct; 39(5):525-33. PubMed ID: 16139885
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of CRA 1000, a non-peptide antagonist of corticotropin-releasing factor receptor type 1, on adaptive behaviour in the rat.
    Harro J; Tõnissaar M; Eller M
    Neuropeptides; 2001 Apr; 35(2):100-9. PubMed ID: 11384205
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CRF type 1 receptors of the medial amygdala modulate inhibitory avoidance responses in the elevated T-maze.
    Vicentini JE; Céspedes IC; Nascimento JO; Bittencourt JC; Viana MB
    Horm Behav; 2014 Mar; 65(3):195-202. PubMed ID: 24472740
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SN003, a CRF
    Wróbel A; Doboszewska U; Rechberger E; Wlaź P; Rechberger T
    Eur J Pharmacol; 2017 Oct; 812():216-224. PubMed ID: 28705713
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dopamine-dependent responses to cocaine depend on corticotropin-releasing factor receptor subtypes.
    Lu L; Liu Z; Huang M; Zhang Z
    J Neurochem; 2003 Mar; 84(6):1378-86. PubMed ID: 12614338
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Region-specific effects of brain corticotropin-releasing factor receptor type 1 blockade on footshock-stress- or drug-priming-induced reinstatement of morphine conditioned place preference in rats.
    Wang J; Fang Q; Liu Z; Lu L
    Psychopharmacology (Berl); 2006 Mar; 185(1):19-28. PubMed ID: 16374599
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential roles of corticotropin-releasing factor receptor subtypes 1 and 2 in opiate withdrawal and in relapse to opiate dependence.
    Lu L; Liu D; Ceng X; Ma L
    Eur J Neurosci; 2000 Dec; 12(12):4398-404. PubMed ID: 11122350
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The GABA(B) receptor antagonist CGP36742 improves learned helplessness in rats.
    Nakagawa Y; Sasaki A; Takashima T
    Eur J Pharmacol; 1999 Sep; 381(1):1-7. PubMed ID: 10528127
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CRF
    Verdouw PM; van Esterik JC; Peeters BW; Millan MJ; Groenink L
    Pharmacol Biochem Behav; 2017 Mar; 154():11-19. PubMed ID: 28089628
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Corticotropin-releasing factor receptor type 1 mediates stress-induced relapse to cocaine-conditioned place preference in rats.
    Lu L; Liu D; Ceng X
    Eur J Pharmacol; 2001 Mar; 415(2-3):203-8. PubMed ID: 11275000
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Suppression of conditioned fear by administration of CRF receptor antagonist CP-154,526.
    Hikichi T; Akiyoshi J; Yamamoto Y; Tsutsumi T; Isogawa K; Nagayama H
    Pharmacopsychiatry; 2000 Sep; 33(5):189-93. PubMed ID: 11071021
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of chronic administration of a CRF(1) receptor antagonist, CRA1000, on locomotor activity and endocrine responses to stress.
    Ohata H; Arai K; Shibasaki T
    Eur J Pharmacol; 2002 Dec; 457(2-3):201-6. PubMed ID: 12464367
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Corticotropin-releasing hormone receptors mediate consensus interferon-alpha YM643-induced depression-like behavior in mice.
    Yamano M; Yuki H; Yasuda S; Miyata K
    J Pharmacol Exp Ther; 2000 Jan; 292(1):181-7. PubMed ID: 10604946
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.